LFT-23664-47999
1 vaccination
1 coded response
10 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 083 / NJ
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Registered in v-safe
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2020-12-29
Survey response — day 0, dose 1MedDRA: Dizziness, Hyperhidrosis — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Dizziness/ diaphoreticMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-29
Report sent to call center — day 0, dose 1Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2020-12-30
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
-
2021-01-05
Call successfulCompleted over the phone
- 2021-01-07
- 2021-01-12
- 2021-03-30
- 2021-07-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Dizziness/ diaphoretic
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release